These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16673270)

  • 21. Reducing blood loss at myomectomy with use of a gelatin-thrombin matrix hemostatic sealant.
    Raga F; Sanz-Cortes M; Bonilla F; Casañ EM; Bonilla-Musoles F
    Fertil Steril; 2009 Jul; 92(1):356-60. PubMed ID: 19423098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma-derived biological medicines used to promote haemostasis.
    Ofosu FA; Freedman J; Semple JW
    Thromb Haemost; 2008 May; 99(5):851-62. PubMed ID: 18449414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Standardization and clinical utility of thrombin-generation assays.
    Berntorp E; Salvagno GL
    Semin Thromb Hemost; 2008 Oct; 34(7):670-82. PubMed ID: 19085768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
    Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
    Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioavailability and relative tissue distribution of [125I]-recombinant human thrombin following intravenous or subcutaneous administration to non-human primates.
    Visich JE; Byrnes-Blake KA; Lewis KB; Meengs B; Rogge MC
    J Thromb Haemost; 2006 Sep; 4(9):1962-8. PubMed ID: 16796709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary and secondary hemostatic functionalities of rehydrated, lyophilized platelets.
    Fischer TH; Bode AP; Parker BR; Russell KE; Bender DE; Ramer JK; Read MS
    Transfusion; 2006 Nov; 46(11):1943-50. PubMed ID: 17076850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of immunogenic potentials of bovine thrombin preparations.
    Zhu H; Hoppensteadt D; Adiguzel C; Bick RL; Fareed J
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):41-9. PubMed ID: 19117966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk and clinical significance of developing antibodies induced by topical thrombin preparations.
    Dorion RP; Hamati HF; Landis B; Frey C; Heydt D; Carey D
    Arch Pathol Lab Med; 1998 Oct; 122(10):887-94. PubMed ID: 9786349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impairment of the hemostatic potential of platelets during storage as evaluated by flow cytometry, thrombin generation, and thrombelastography under conditions promoting formation of coated platelets.
    Svendsen MS; Rojkjaer R; Kristensen AT; Salado-Jimena JA; Kjalke M; Johansson PI
    Transfusion; 2007 Nov; 47(11):2057-65. PubMed ID: 17958535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Large-scale preparation of thrombin from human plasma.
    Aizawa P; Winge S; Karlsson G
    Thromb Res; 2008; 122(4):560-7. PubMed ID: 18329699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune-mediated coagulopathy: a case report.
    Naoum JJ
    Pharmacotherapy; 2009 Jul; 29(7 Pt 2):13S-7S. PubMed ID: 19558280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on pathogen reduction technology for therapeutic plasma: an overview.
    Solheim BG; Seghatchian J
    Transfus Apher Sci; 2006 Aug; 35(1):83-90. PubMed ID: 16934528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical hemostasis: a valuable adjunct to control bleeding in the operating room, with a special focus on thrombin and fibrin sealants.
    Doria C; Vaccino S
    Expert Opin Biol Ther; 2009 Feb; 9(2):243-7. PubMed ID: 19236254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of procoagulants and anticoagulants in the development of venous thromboembolism.
    Bertina RM
    Thromb Res; 2009; 123 Suppl 4():S41-5. PubMed ID: 19303503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombin generation and fibrin clot structure.
    Wolberg AS
    Blood Rev; 2007 May; 21(3):131-42. PubMed ID: 17208341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and characterization of human thrombin for use in a fibrin glue.
    Rock G; Neurath D; Semple E; Harvey M; Freedman M
    Transfus Med; 2007 Jun; 17(3):187-91. PubMed ID: 17561860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombin affects hemostatic response to recombinant activated factor VII in factor VIII deficient plasma.
    Szlam F; Taketomi T; Sheppard CA; Kempton CL; Levy JH; Tanaka KA
    Anesth Analg; 2008 Mar; 106(3):719-24, table of contents. PubMed ID: 18292408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrastructure of activated mouse platelets: a qualitative scanning electron microscopy study.
    Pretorius E; Oberholzer HM; Smit E
    Microsc Res Tech; 2008 Jun; 71(6):413-7. PubMed ID: 18300287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Achieving hemostasis in the surgical field.
    Boucher BA; Traub O
    Pharmacotherapy; 2009 Jul; 29(7 Pt 2):2S-7S. PubMed ID: 19558278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-yield preparation of recombinant human α-thrombin for therapeutic use.
    Meta A; Hirashima M; Imamura T; Kawamura R; Yano K; Uehara K; Nakashima T
    J Biosci Bioeng; 2015 Oct; 120(4):432-7. PubMed ID: 25735923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.